BaKtmns Review: High-Pressure Tactics and Cloned-Firm Red Flags
We brought BaKtmns onto a single screen — licensing, ownership, and the withdrawal trail — and read what the evidence showed. The picture that emerged is one of elevated risk: BaKtmns has drawn cautions from…